Contract Manufacturing for Medical Devices: How to Choose and What It Costs

Contract manufacturing for medical devices is not ordinary outsourcing with extra paperwork. The manufacturer becomes part of your regulated quality system: their processes are validated, their records are auditable, and their deviations become your regulatory problem. Choosing well is a compliance decision as much as a commercial one, and the cost of choosing badly is measured in re-validation and lost quarters.

The right moment is when the design concept is stable but the details are still open — typically at the end of design development, before design freeze. Early enough that manufacturability, tolerances and process capability shape the design; late enough that you are not paying a factory to iterate concepts.

Involving a contract manufacturer after design freeze usually means either accepting their process limitations or paying for changes you could have avoided.

Class I devices sit near the bottom of every range; sterile, implantable or software-containing Class II and III devices sit at or above the top. Our medical device development services cover the design and documentation side that a contract manufacturer expects to receive.

Audit the facility in person before signing, and speak to two customers who have been through a regulatory inspection with them. A slick quote and a certificate on the wall tell you nothing about how the manufacturer behaves when a lot fails at final inspection.

Most contract manufacturing failures in medical devices are not technical — they are governance failures. The quality agreement, not the supply agreement, decides who owns change control, who signs deviations, who releases lots, and who answers an inspector's question about a process the supplier runs.

Write it before the first pilot build, and review it whenever the device, the process, or the regulation changes. Supplier-initiated process changes that never reach your change board are the single most common source of unpleasant surprises at audit.

Budget for a second source earlier than feels comfortable.

Dual-sourcing a sterile injection-molded housing costs another validation cycle, but a single qualified supplier with a single mold is a single point of failure for your whole revenue line — and a tooling crash mid-quarter takes 12 to 20 weeks to recover from if there is no qualified alternative already in the file.

Where a full second source is not affordable, at minimum keep a validated tooling backup, a documented process recipe outside the supplier's network, and a transfer plan you have rehearsed on paper.

It is production of a medical device by an outside manufacturer operating under a quality management system, usually ISO 13485, on behalf of the legal manufacturer. The engagement covers technology transfer, process validation, pilot builds, lot-traceable commercial production and post-market support such as complaint investigation and CAPA.

Expect $25,000-$150,000 for NRE and technology transfer, $30,000-$120,000 for process validation per critical process, $20,000-$200,000 for tooling and fixtures, and $10,000-$60,000 for test method validation. Minimum order quantities usually fall between 500 and 5,000 units, and first commercial lot typically lands six to twelve months after signing.

At minimum a current ISO 13485 certificate whose scope covers your device type and processes, plus registration with the relevant regulator for the markets you sell into. Ask for inspection history, open and closed audit findings with evidence, and validation documentation for the specific processes your device needs.

A medical contract manufacturer is not just a factory with a cleanroom; it is a regulated partner whose quality system becomes part of your submission. You remain the legal manufacturer, so their process validation, complaint handling and change control have to satisfy your auditors.

That is why supplier selection happens during design, not after: transferring a frozen design to a facility that cannot validate your process is the most expensive discovery in the program.

Bring the manufacturer into design reviews while the geometry is still soft. Their process engineers will flag tolerances that cannot be held in a validated moulding process, materials that will not survive the chosen sterilization method, and assembly steps that cannot be verified in-line.

Every one of those changes is nearly free at concept stage and costs a revalidation cycle after design freeze.

Formalise the relationship with a quality agreement that names who owns each activity, and require change notification for any material, tooling or process change - unannounced supplier changes are a leading cause of field issues.

The handoff, not the contract, is where medical device programs slip. Tech transfer is a documented package plus a proving run, and regulators expect evidence that the receiving site can reproduce your device within its validated state. Budget eight to sixteen weeks for a Class II device and treat the transfer as a project with its own schedule, owner and acceptance criteria rather than an email of CAD files.

Process validation cost tracks the number of critical process parameters, not the size of the device. A single-cavity injection-molded housing with two critical dimensions might validate for $12,000-$25,000. An assembly with adhesive cure, laser weld and sterile packaging can run $60,000-$150,000 across the three qualification stages.

Work with LA NPDT: if you are moving from here to execution, start with our low-volume manufacturing or talk to us about design for manufacturing.